Product Code: TMRGL1169
Continuous Glucose Monitoring Market - Scope of Report
TMR's report on the global continuous glucose monitoring market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides the overall revenue of the global continuous glucose monitoring market for the period 2017-2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global continuous glucose monitoring market for the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global continuous glucose monitoring market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global continuous glucose monitoring market.
The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global continuous glucose monitoring market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global continuous glucose monitoring market. The next section of the continuous glucose monitoring market report highlights the USPs, which include COVID-19 pandemic impact on industry (value chain and short/mid/long term impact), prevalence and incidence rate of diabetes across the globe, technological advancements, pricing analysis, and overview of point-of-care testing.
The report delves into the competition landscape of the global continuous glucose monitoring market. Key players operating in the global continuous glucose monitoring market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global continuous glucose monitoring market in report.
Key Questions Answered in Continuous Glucose Monitoring Market Report
What are the sales/revenue generated by continuous glucose monitoring devices during the forecast period?
What are the key trends in the global continuous glucose monitoring market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which segment will have the highest revenue by 2028 and which segment will grow at the highest CAGR during the forecast period?
Strengths and weaknesses of major players
Competitive analysis of major players (2020)
Continuous Glucose Monitoring Market - Research Objectives and Research Approach
The comprehensive report on the global continuous glucose monitoring market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and health care compliances laid down by accredited agencies in the purview of research in the global continuous glucose monitoring market. It is followed by market introduction, market dynamics, and an overview of the global continuous glucose monitoring market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the global continuous glucose monitoring market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
Revenue generated by prominent manufacturers has been mapped to ascertain the size of the global continuous glucose monitoring market in terms of value. The forecast presented here assesses the total revenue generated in the global continuous glucose monitoring market. In order to provide an accurate forecast, we initiated by sizing up the current global continuous glucose monitoring market with the help of the parent market.
The report analyzes the global continuous glucose monitoring market in terms of device/brand and country/sub-region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2028 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global continuous glucose monitoring market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Continuous Glucose Monitoring Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Market Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Continuous Glucose Monitoring Market Analysis and Forecast, 2017-2028
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. Technological Advancements
- 5.2. Prevalence & Incidence rate of Diabetes across globe
- 5.3. Pricing Analysis of devices
- 5.4. Overview of Point-of-care Testing
- 5.5. COVID-19 pandemic impact on Global Continuous Glucose Monitoring Market
6. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Device/Brand
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017-2028
- 6.3.1. Guardian Real Time CGM System
- 6.3.2. FreeStyle Navigator
- 6.3.3. Dexcom Seven Plus CGM System
- 6.3.4. Dexcom G4 Platinum
- 6.3.5. MiniMed Paradigm Revel/Veo Systems
- 6.3.6. Others
- 6.4. Global Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand,2021-2028
7. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Country/Sub-region
- 7.1. Key Findings
- 7.2. Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Region
- 7.2.1. North America
- 7.2.2. Europe
- 7.2.3. Asia Pacific
- 7.2.4. Latin America
- 7.2.5. Middle East & Africa
- 7.3. Global Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/Region,2017-2028
8. North America Continuous Glucose Monitoring Market Analysis and Forecast
- 8.1. Introduction
- 8.2. North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017-2028
- 8.2.1. Guardian Real Time CGM System
- 8.2.2. FreeStyle Navigator
- 8.2.3. Dexcom Seven Plus CGM System
- 8.2.4. Dexcom G4 Platinum
- 8.2.5. MiniMed Paradigm Revel/Veo Systems
- 8.2.6. Others
- 8.3. North America Continuous Glucose Monitoring Market Analysis, by Country, 2017-2028
- 8.3.1. U.S.
- 8.3.2. Canada
- 8.4. North America Continuous Glucose Monitoring Market Attractiveness Analysis, 2021-2028
- 8.4.1. By Device/Brand
- 8.4.2. By Country/Sub-region
9. Europe Continuous Glucose Monitoring Market Analysis and Forecast
- 9.1. Introduction
- 9.2. Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017-2028
- 9.2.1. Guardian Real Time CGM System
- 9.2.2. FreeStyle Navigator
- 9.2.3. Dexcom Seven Plus CGM System
- 9.2.4. Dexcom G4 Platinum
- 9.2.5. MiniMed Paradigm Revel/Veo Systems
- 9.2.6. Others
- 9.3. Europe Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017-2028
- 9.3.1. Germany
- 9.3.2. U.K.
- 9.3.3. France
- 9.3.4. Italy
- 9.3.5. Spain
- 9.3.6. Rest of Europe
- 9.4. Europe Continuous Glucose Monitoring Market Attractiveness Analysis, 2021-2028
- 9.4.1. By Device/Brand
- 9.4.2. By Country/Sub-region
10. Asia Pacific Continuous Glucose Monitoring Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017-2028
- 10.2.1. Guardian Real Time CGM System
- 10.2.2. FreeStyle Navigator
- 10.2.3. Dexcom Seven Plus CGM System
- 10.2.4. Dexcom G4 Platinum
- 10.2.5. MiniMed Paradigm Revel/Veo Systems
- 10.3. Asia Pacific Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017-2028
- 10.3.1. China
- 10.3.2. Japan
- 10.3.3. India
- 10.3.4. Australia & New Zealand
- 10.3.5. Rest of Asia Pacific
- 10.4. Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, 2021-2028
- 10.4.1. By Device/Brand
- 10.4.2. By Country/Sub-region
11. Latin America Continuous Glucose Monitoring Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017-2028
- 11.2.1. Guardian Real Time CGM System
- 11.2.2. FreeStyle Navigator
- 11.2.3. Dexcom Seven Plus CGM System
- 11.2.4. Dexcom G4 Platinum
- 11.2.5. MiniMed Paradigm Revel/Veo Systems
- 11.3. Latin America Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017-2028
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of Latin America
- 11.4. Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, 2021-2028
- 11.4.1. By Device/Brand
- 11.4.2. By Country/Sub-region
12. Middle East & Africa Continuous Glucose Monitoring Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017-2028
- 12.2.1. Guardian Real Time CGM System
- 12.2.2. FreeStyle Navigator
- 12.2.3. Dexcom Seven Plus CGM System
- 12.2.4. Dexcom G4 Platinum
- 12.2.5. MiniMed Paradigm Revel/Veo Systems
- 12.3. Middle East & Africa Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017-2028
- 12.3.1. GCC Countries
- 12.3.2. South Africa
- 12.3.3. Rest of Middle East & Africa
- 12.4. Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, 2021-2028
- 12.4.1. By Device/Brand
- 12.4.2. By Country/Sub-region
13. Competitive Landscape
- 13.1. Company Profiles (2020)
- 13.1.1. Abbott
- 13.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.1.1.2. Product Portfolio
- 13.1.1.3. Financial Overview
- 13.1.1.4. Strategic Overview
- 13.1.1.5. SWOT Analysis
- 13.1.2. Bayer AG
- 13.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.1.2.2. Product Portfolio
- 13.1.2.3. Financial Overview
- 13.1.2.4. Strategic Overview
- 13.1.2.5. SWOT Analysis
- 13.1.3. Dexcom, Inc.
- 13.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.1.3.2. Product Portfolio
- 13.1.3.3. Financial Overview
- 13.1.3.4. Strategic Overview
- 13.1.3.5. SWOT Analysis
- 13.1.4. Glysens Incorporated
- 13.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.1.4.2. Product Portfolio
- 13.1.4.3. Strategic Overview
- 13.1.4.4. SWOT Analysis
- 13.1.5. Insulet Corporation
- 13.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.1.5.2. Product Portfolio
- 13.1.5.3. Financial Overview
- 13.1.5.4. Strategic Overview
- 13.1.5.5. SWOT Analysis
- 13.1.6. Medtronic
- 13.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.1.6.2. Product Portfolio
- 13.1.6.3. Financial Overview
- 13.1.6.4. Strategic Overview
- 13.1.6.5. SWOT Analysis
- 13.1.7. Nova Biomedical Corporation
- 13.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.1.7.2. Product Portfolio
- 13.1.7.3. Financial Overview
- 13.1.7.4. Strategic Overview
- 13.1.7.5. SWOT Analysis
- 13.1.8. Senseonics Incorporated
- 13.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.1.8.2. Product Portfolio
- 13.1.8.3. Strategic Overview
- 13.1.8.4. SWOT Analysis
- 13.1.9. Livongo
- 13.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.1.9.2. Product Portfolio
- 13.1.9.3. Strategic Overview
- 13.1.9.4. SWOT Analysis
- 13.1.10. BeatO
- 13.1.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.1.10.2. Product Portfolio
- 13.1.10.3. Strategic Overview
- 13.1.10.4. SWOT Analysis
- 13.1.11. Jana Care
- 13.1.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.1.11.2. Product Portfolio
- 13.1.11.3. Strategic Overview
- 13.1.11.4. SWOT Analysis
- 13.1.12. iXensor
- 13.1.12.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.1.12.2. Product Portfolio
- 13.1.12.3. Strategic Overview
- 13.1.12.4. SWOT Analysis
- 13.1.13. DiaMonTech AG
- 13.1.13.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.1.13.2. Product Portfolio
- 13.1.13.3. Financial Overview
- 13.1.13.4. Strategic Overview
- 13.1.13.5. SWOT Analysis